Global Heparin Anticoagulant Market Outlook 2021: Global Opportunity and Demand Analysis, Market Forecast, 2022-2030

The global heparin anticoagulant market is anticipated to rise at a value CAGR of 1.7% over 20202028. According to a study published by Insure Insights on the Global Heparin Anticoagulant Market. Heparin is an anticoagulant. It acts by preventing clotting in the blood caused by certain medical conditions or medical procedures. It is also used before surgery in treating cardiac disorders. It is used in the treatment of heart attacks and unstable angina. It is given either by the IV route or the subcutaneous route. Favorable government initiatives for better treatment have fueled the market further.

Top Driver: The high rate of occurrence of cardiovascular disorders has boosted the market.
The rise in the incidences of cardiac disorders has triggered the demand for the market. For instance, the Centre for Disease Control and Prevention has estimated that coronary heart disease caused the deaths of 365,914 people in the year 2017. The rise in the number of accidents and surgeries worldwide, an increase in awareness regarding the use of heparin for anticoagulant effects, and an increase in the geriatric population have boosted the overall market.
Low Molecular Weight Heparin has dominated growth in the Global Heparin Anticoagulant Market.
Based on the type, the 3D Heparin Anticoagulantsegment has held the highest segmental growth. As they efficiently prevent blood clots in the treatment of venous thromboembolism and also aid in the treatment of myocardial infarction, Low molecular weight heparin does not need anticoagulation monitoring and has a lower incidence of heparin-induced thrombocytopenia.
In terms of the route of administration, the subcutaneous route segment has held the largest growth in the market as it is preferred owing to ease of administration, and anticoagulants are required in small amounts due to the need for a reduced duration of treatment. Based on the application, the coronary artery disease segment has held the most significant growth, owing to the rise in cases of CAD. Lifestyle habits like smoking and consumption of alcohol have further triggered the growth.

North America dominated the regional market with the increase in the incidence of cardiovascular disorders.
The rise in the incidence of cardiovascular disorders like atrial fibrillation and coronary artery disease has significantly fueled the growth of North America. The availability of sophisticated healthcare infrastructure and the rise in healthcare expenditure have further been attributed to the regional growth of the market. The rise in sports activities in the region and a considerable rise in injuries related to them have fueled the growth opportunities for the region. Furthermore, the increase in patient awareness has boosted the overall regional revenue.
Product launches, innovations, strategic collaborations, mergers, and acquisitions are the major strategies of competitors.
The players in the global heparin anticoagulant market are fragmented. The key competitors in the Global Heparin Anticoagulant Market are GlaxoSmithKline plc; Pfizer, Inc; Leo Pharma A/S; Sanofi; Dr. Reddys Laboratories Ltd.; Aspen Holdings; B. Braun Medical Inc.; Fresenius SE & Co. KGaA; Teva Pharmaceutical Industries Ltd.; and Baxter.
GlaxoSmithKline plc is one of the key competitors in the global heparin anticoagulant market. In January 2019, GlaxoSmithKline plc announced the acquisition of TESARO. They are an oncology-based company. This acquisition was made by GlaxoSmithKline to strengthen its product portfolio with oncology drugs. The deal for the acquisition was made for USD 5.1 billion.
Baxter is a popular competitor in the global heparin anticoagulant market. In December 2019, Baxter announced the acquisition of Seprafilm Adhesion Barrier and related assets from Sanofi. The deal was made for USD 350 million. This acquisition was made by Baxter to expand its product portfolio.


Scope of the Report

By Type
Low Molecular Weight Heparin
Ultra-low Molecular Weight Heparin
Unfractionated Heparin

By Route of Administration
Intravenous
Subcutaneous

By Application
Venous Thromboembolism
Atrial Fibrillation
Coronary Artery Disease
Others

By Region
North America
Europe
Asia Pacific
Rest Of World

Key Reasons to Purchase this Report
1. It provides a technological development map over time to understand the growth rate of the industry.
2. The report offers a dynamic method to various factors that drive or restrain the growth of the market.
3. It renders a definite analysis for changing competitive dynamics.
4. It builds a seven-year estimate based on how the market is predicted to grow.

Chapter 1 Overview And Scope
1.1 Market Vision
1.1.1 Market Definition
1.1.2 Market Scope
1.2 Market Segmentation

Chapter 2 Our Research Practice
2.1 Our Research Methodology
2.2 Data Triangulation
2.3 Data Sources
2.4 Assumptions for the study
2.5 Approach Adopted

Chapter 3 Executive Summary
3.1 Market Snapshot
3.2 Regional Snapshot
3.3 Segment Summary

Chapter 4 Covid-19 Impact Analysis
4.1 Overview
4.2 Prevalence analysis
4.3 Key Factor Impact Analysis

Chapter 5 Global Heparin Anticoagulant Market Forces
5.1 Whats Driving the Market
5.2 Porters Five Forces Analysis
5.2.1 Power of Suppliers
5.2.2 Threats From New Entrants
5.2.3 Power of Buyer
5.2.4 Threat From Substitute Product
5.2.5 Degree of Competition

Chapter 6 Global Heparin Anticoagulant Market -Industry Snapshots
6.1 Overview
6.1.1 Global Heparin Anticoagulant Market Value, 2019 - 2028, (US$ Bn)
6.2 Market Overview
6.2.1 Drivers Analysis
6.2.2 Restraint/Challenges analysis
6.2.3 Opportunity Analysis
6.3 Supply Chain/Value Chain Analysis
6.4 Market SWOT Analysis

Chapter 7 Global Heparin Anticoagulant Market Analysis, by Type
7.1 Overview
7.2 Key Findings for Heparin Anticoagulant Market- By Type
7.2.1 Heparin Anticoagulant Market- Low Molecular Weight Heparin
7.2.2 Heparin Anticoagulant Market- Ultra-low Molecular Weight Heparin
7.2.3 Heparin Anticoagulant Market- Unfractionated Heparin

Chapter 8 Global Heparin Anticoagulant Market Analysis, by Route of Administration
8.1 Overview
8.2 Key Findings for Heparin Anticoagulant Market- By Route of Administration
8.2.1 Heparin Anticoagulant Market- Intravenous
8.2.2 Heparin Anticoagulant Market- Subcutaneous

Chapter 9 Global Heparin Anticoagulant Market Analysis, by Application
9.1 Overview
9.2 Key Findings for Heparin Anticoagulant Market- By Application
9.2.1 Heparin Anticoagulant Market- Venous Thromboembolism
9.2.2 Heparin Anticoagulant Market- Atrial Fibrillation
9.2.3 Heparin Anticoagulant Market- Coronary Artery Disease
9.2.4 Heparin Anticoagulant Market- Others

Chapter 10 Heparin Anticoagulant Market Analysis by Region
10.1 Key Findings for Heparin Anticoagulant Market- By region
10.2 Overview
10.2.1 Global Heparin Anticoagulant Market Analysis, By Type, 2019 - 2028
10.2.2 Global Heparin Anticoagulant Market Analysis, By Route of Administration, 2019 - 2028
10.2.3 Global Heparin Anticoagulant Market Analysis, By Application, 2019 - 2028
10.3 Heparin Anticoagulant Market North America
10.3.1 Overview
10.3.2 U.S.
10.3.3 Canada
10.3.4 Mexico
10.3.5 North America Market, By Type
10.3.6 North America Market, By Route of Administration
10.3.7 North America Market, By Application
10.4 Heparin Anticoagulant Market Europe
10.4.1 Overview
10.4.2 Germany
10.4.3 United Kingdom
10.4.4 France
10.4.5 Italy
10.4.6 Rest Of Europe
10.4.7 Europe Market, By Type
10.4.8 Europe Market, By Route of Administration
10.4.9 Europe market by, Application
10.5 Heparin Anticoagulant Market Asia Pacific
10.5.1 Overview
10.5.2 China
10.5.3 Japan
10.5.4 India
10.5.5 Rest of APAC
10.5.6 Asia Pacific Market, By Type
10.5.7 Asia Pacific Market, By Route of Administration
10.5.8 Asia Pacific Market, By Application
10.6 Heparin Anticoagulant Market Rest Of World
10.6.1 Overview
10.6.2 Middle East & Africa (MEA)
10.6.3 Latin America
10.6.4 Rest Of World
10.6.5 Latin America, Middle East and Africa Market, By Type
10.6.6 Latin America, Middle East and Africa Market, By Route of Administration
10.6.7 Latin America, Middle East and Africa Market, By Application

Chapter 11 Market Competition Analysis
11.1 Market Share/Positioning Analysis
11.1.1 Market Positioning of Key Vendors, 2019
11.1.2 Key Strategies Adopted by the Leading Players
11.1.3 Recent Developments

Chapter 12 Company Profiles- Snapshot
12.1 GlaxoSmithKline plc
12.1.1 Business Fundamentals
12.1.2 Financial Snapshots
12.1.3 Product Portfolio
12.1.4 Recent Developments
12.2 Pfizer, Inc.
12.3 Leo Pharma A/S
12.4 Sanofi
12.5 Dr. Reddys Laboratories Ltd.
12.6 Aspen Holdings
12.7 B. Braun Medical Inc
12.8 Fresenius SE & Co. KGaA
12.9 Teva Pharmaceutical Industries Ltd.
12.10 Baxter
*More than 10 Companies are profiled in this Research Report*
*Financials would be provided on a best efforts basis for private companies

Chapter 13 Appendix

List Of Tables

TABLE 1 Heparin Anticoagulant market by Type 1, 2019 - 2028 (USD Million)
TABLE 2 Heparin Anticoagulant market by Type 2, 2019 - 2028 (USD Million)
TABLE 3 Heparin Anticoagulant market by Type 3, 2019 - 2028 (USD Million)
TABLE 4 Heparin Anticoagulant market by Route of Administration 1, 2019 - 2028 (USD Million)
TABLE 5 Heparin Anticoagulant market by Route of Administration 2, 2019 - 2028 (USD Million)
TABLE 6 Heparin Anticoagulant market by Application 1, 2019 - 2028 (USD Million)
TABLE 7 Heparin Anticoagulant market by Application 2, 2019 - 2028 (USD Million)
TABLE 8 Heparin Anticoagulant market by Application 3, 2019 - 2028 (USD Million)
TABLE 9 Heparin Anticoagulant market by Application 4, 2019 - 2028 (USD Million)
TABLE 10 Global Heparin Anticoagulant Market Value, By Type, 2019 - 2028 (US$ Bn)
TABLE 11 Global Heparin Anticoagulant Market Value, By Route of Administration, 2019 - 2028 (US$ Bn)
TABLE 12 Global Heparin Anticoagulant Market Value, By Application, 2019 - 2028 (US$ Bn)
TABLE 13 Heparin Anticoagulant Market Analysis by North America (USD Million), 2019 - 2028
TABLE 14 U.S. Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 15 U.S. Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 16 U.S. Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 17 U.S. Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 18 Canada Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 19 Canada Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 20 Canada Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 21 Canada Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 22 Mexico Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 23 Mexico Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 24 Mexico Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 25 Mexico Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 26 Heparin Anticoagulant Market Analysis by Europe (USD Million), 2019 - 2028
TABLE 27 Germany Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 28 Germany Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 29 Germany Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 30 Germany Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 31 United Kingdom Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 32 United Kingdom Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 33 United Kingdom Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 34 United Kingdom Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 35 France Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 36 France Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 37 France Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 38 France Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 39 Italy Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 40 Italy Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 41 Italy Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 42 Italy Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 43 Rest Of Europe Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 44 Rest Of Europe Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 45 Rest Of Europe Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 46 Rest of Europe Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 47 Heparin Anticoagulant Market Analysis by Asia Pacific (USD Million), 2019 - 2028
TABLE 48 China Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 49 China Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 50 China Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 51 China Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 52 Japan Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 53 Japan Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 54 Japan Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 55 Japan Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 56 India Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 57 India Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 58 India Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 59 India Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 60 Rest of APAC Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 61 Rest of APAC Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 62 Rest of APAC Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 63 Rest of APAC Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 64 Heparin Anticoagulant Market Analysis by Rest Of World (USD Million), 2019 - 2028
TABLE 65 Middle East & Africa (MEA) Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 66 Middle East & Africa (MEA) Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 67 Middle East & Africa (MEA) Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 68 Middle East & Africa (MEA) Market, By Application, 2019 - 2028 (USD Million)
TABLE 69 Latin America Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 70 Latin America Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 71 Latin America Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 72 Latin America Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)
TABLE 73 Rest Of World Heparin Anticoagulant Market, 2019 - 2028 (USD Million)
TABLE 74 Rest Of World Heparin Anticoagulant Market, By Type, 2019 - 2028 (USD Million)
TABLE 75 Rest Of World Heparin Anticoagulant Market, By Route of Administration, 2019 - 2028 (USD Million)
TABLE 76 Rest Of World Heparin Anticoagulant Market, By Application, 2019 - 2028 (USD Million)

List Of Figures

FIG. 1 Global Heparin Anticoagulant: Market Segmentation
FIG. 2 Global Heparin Anticoagulant Market: Research Methodology
FIG. 3 Top-Down and Bottom Up Approach
FIG. 4 Market Snapshot
FIG. 5 Porters Five Forces Analysis
FIG. 6 Global Heparin Anticoagulant Market Value, 2019 - 2028, (US$ Bn)
FIG. 7 Supply Chain/Value Chain Analysis
FIG. 8 Global Heparin Anticoagulant Market Value Contribution, By Type, 2019 & 2026 (%)
FIG. 9 Global Heparin Anticoagulant Market Value Contribution, By Route of Administration, 2019 & 2026 (%)
FIG. 10 Global Heparin Anticoagulant Market Value Contribution, By Application, 2019 & 2026 (%)
FIG. 11 Global Heparin Anticoagulant Market Value, 2019 - 2028, (US$ Bn)
FIG. 12 North America Heparin Anticoagulant Market Value, 2019 - 2028, (US$ Bn)
FIG. 13 Heparin Anticoagulant Market Segment 1 North America
FIG. 14 Heparin Anticoagulant Market Segment 2 North America
FIG. 15 Heparin Anticoagulant Market Segment 3 North America
FIG. 16 Heparin Anticoagulant U.S. outlook, 2019 & 2026
FIG. 17 Heparin Anticoagulant Canada outlook, 2019 & 2026
FIG. 18 Heparin Anticoagulant Mexico outlook, 2019 & 2026
FIG. 19 Europe Heparin Anticoagulant Market Value, 2019 - 2028, (US$ Bn)
FIG. 20 Heparin Anticoagulant Market Segment 1 Europe
FIG. 21 Heparin Anticoagulant Market Segment 2 Europe
FIG. 22 Heparin Anticoagulant Market Segment 3 Europe
FIG. 23 Heparin Anticoagulant Germany outlook, 2019 & 2026
FIG. 24 Heparin Anticoagulant United Kingdom outlook, 2019 & 2026
FIG. 25 Heparin Anticoagulant France outlook, 2019 & 2026
FIG. 26 Heparin Anticoagulant Italy outlook, 2019 & 2026
FIG. 27 Heparin Anticoagulant Rest Of Europe outlook, 2019 & 2026
FIG. 28 Asia Pacific Heparin Anticoagulant Market Value, 2019 - 2028, (US$ Bn)
FIG. 29 Heparin Anticoagulant Market Segment 1 Asia Pacific
FIG. 30 Heparin Anticoagulant Market Segment 2 Asia Pacific
FIG. 31 Heparin Anticoagulant Market Segment 2 Asia Pacific
FIG. 32 Heparin Anticoagulant China outlook, 2019 & 2026
FIG. 33 Heparin Anticoagulant Japan outlook, 2019 & 2026
FIG. 34 Heparin Anticoagulant India outlook, 2019 & 2026
FIG. 35 Heparin Anticoagulant Rest of APAC outlook, 2019 & 2026
FIG. 36 Rest Of World Heparin Anticoagulant Market Value, 2019 - 2028, (US$ Bn)
FIG. 37 Heparin Anticoagulant Market Segment 1 Rest Of World
FIG. 38 Heparin Anticoagulant Market Segment 2 Rest Of World
FIG. 39 Heparin Anticoagulant Market Segment 3 Rest Of World
FIG. 40 Heparin Anticoagulant Middle East & Africa (MEA) outlook, 2019 & 2026
FIG. 41 Heparin Anticoagulant Latin America outlook, 2019 & 2026
FIG. 42 Heparin Anticoagulant Rest Of World outlook, 2019 & 2026

Companies Mentioned

Pfizer Inc.
LEO Pharma A/S
Dr. Reddys Laboratories Ltd.
GlaxoSmithKline plc
Sanofi
Aspen Holdings
Fresenius SE & Co. KGaA
B. Braun Medical, Inc.
Sandoz (Novartis AG)

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available